Actinium Pharmaceuticals, Inc. ATNM
AMEX · United States · Health Technology
$1.17+0.02 (+1.74%)
Market closed· · USD · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
Market closed· · USD · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
| Quarter | Report date | Actual EPS | Estimated EPS | EPS surprise | Actual revenue | Revenue surprise | Price reaction |
|---|---|---|---|---|---|---|---|
| Q2 2026 | 2026-08-07 | 0.89 | -0.20 | +545.0% | $35.00M | — | -2.2%$0.79→$0.77 |
| Q1 2026 | 2026-05-08 | -0.18 | -0.22 | +18.2% | — | — | +9.8%$1.22→$1.34 |
| Q4 2025 | 2026-03-30 | -0.19 | -0.19 | 0.0% | — | — | -3.4%$1.03→$1.00 |
| Q3 2025 | 2025-11-14 | -0.16 | -0.32 | +50.0% | — | — | +16.0%$1.25→$1.45 |
| Q2 2025 | 2025-08-08 | -0.22 | -0.35 | +37.1% | — | — | — |
| Q1 2025 | 2025-05-09 | -0.51 | -0.28 | -82.1% | — | — | — |
| Q4 2024 | 2025-03-31 | -0.21 | -0.39 | +46.2% | — | — | — |
| Q3 2024 | 2024-11-14 | -0.37 | -0.37 | 0.0% | — | — | — |
The price reaction is the change from the last close before the announcement date to the first close after it - the report may land before the open, during the session or after the close, so this window covers all three. Not investment advice.